A 1965 Life magazine cover featured a heavily altered bionic woman, showcasing new ideas about humanity's potential to enhance and better itself. The image evoked the ultimate question: what makes a human being?
Exploring the topic, Shelley McKellar follows the changes of ideology and technology in medicine in the quest to create the human artificial heart. Looking into the development of heart disease and the fight for a cure, McKellar sets the stage for the engineering feats and hopes of the medical community to defeat heart failure that cost millions of dollars and hundreds of thousands of lives. The promise of being able to overcome heart failure via a replacement part was embodied in the view that anything in the body could be replaced with an artificial entity. Focusing mainly on American developers, who, according to the authors’ research, took on ‘a leadership role’ (p. 10), the book also features worldwide collaboration between surgeons and bioengineers.
The book's great success is its ability to bring to life the complexity of collaborations between engineers, surgeons and general practitioners by giving a voice and a background to research and interaction conducted by all three parties. McKellar introduces the wider history of heart diseases but focuses on the period when cardiovascular diseases were becoming exceedingly important research subjects in the 1960s and 1970s United States. It was propelled by the view that the same technology that got humanity into space should be able to fix a broken heart. As McKellar states, ‘faced with the choice between surgery and prolonged medical treatment, [the US patient] will unhesitatingly choose surgery’ (p. 15). By essentially viewing the body as a combination of impermanent mechanical parts, the bioengineers tended to focus on how the technology was supposed to work and not on the patients’ feelings towards and experience of the technology. This led to a lack of informed consent in the 1960s and 1970s, resulting in a failure to inform patients that they were acting as human experiments for prototypes. In the US, following more than seven hundred deaths and ten thousand injuries in the 1960s due to faulty medical devices, the Food and Drug Administration had no choice but to rule that only those patients whose heart stopped on the operating table could receive an artificial heart. While the development of the artificial heart was not stopped by this ruling – in fact it even furthered research into the function of the heart – it did create a certain principle that has been true to the present day that the artificial heart is ‘not a cure’ (p. 1) but a way to buy more time. During the progression of the development, it became exceedingly apparent that the reality of the bionic person was harder to create than had been initially believed. The human body was hard to imitate and no technology could last inside a human body long-term, especially not a heart, with its finely tuned motorics. McKellar's research into the development of the artificial heart provides an interesting insight into the world of heart disease research and hopes for technological escapism while giving a reminder that a human body is more than just the sum of its parts.
